Platelet-derived growth factor receptor beta identifies mesenchymal stem cells with enhanced engraftment to tissue injury and pro-angiogenic property

Cellular and Molecular Life Sciences

Volumn 75, Issue 3, 2018, Pages 547-561

  Wang, Shan ^a   Mo, Miaohua ^a   Wang, Jinmei ^a   Sadia, Sobia ^a   Shi, Bihua ^a   Fu, Xiaobing ^b   Yu, Lin ^c   Tredget, Edward E ^d   Wu, Yaojiong ^a  

^a TSINGHUA UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Angiogenesis; Mesenchymal stem cells; PDGFR (CD140b); Subpopulation; Wound healing

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; VASCULOTROPIN; PLATELET DERIVED GROWTH FACTOR B;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ENGRAFTMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PLACENTA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE INJURY; UPREGULATION; WOUND CLOSURE; WOUND HEALING; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL SEPARATION; CYTOLOGY; FLOW CYTOMETRY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; NUDE MOUSE; PHYSIOLOGY; PROCEDURES; REGENERATION; STANDARDS;

ANIMALS; CELL SEPARATION; CELLS, CULTURED; FLOW CYTOMETRY; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-SIS; REGENERATION; WOUND HEALING;

EID: 85029601312     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-017-2641-7     Document Type: Article

References (41)

1. Trounson A, McDonald C (2015) Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell 17(1):11–22. doi:10.1016/j.stem.2015.06.007
2. Parekkadan B, Milwid JM (2010) Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12:87–117. doi:10.1146/annurev-bioeng-070909-105309
3. Mo M, Wang S, Zhou Y et al (2016) Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential. Cell Mol Life Sci 73(17):3311–3321. doi:10.1007/s00018-016-2229-7
4. Phinney DG (2012) Functional heterogeneity of mesenchymal stem cells: implications for cell therapy. J Cell Biochem 113(9):2806–2812. doi:10.1002/jcb.24166
5. Hellstrom M, Kalen M, Lindahl P et al (1999) Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126(14):3047–3055
6. Rajkumar VS, Shiwen X, Bostrom M et al (2006) Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am J Pathol 169(6):2254–2265
7. Tokunaga A, Oya T, Ishii Y et al (2008) PDGF receptor beta is a potent regulator of mesenchymal stromal cell function. J Bone Miner Res 23(9):1519–1528. doi:10.1359/Jbmr.080409
8. Lin RZ, Moreno-Luna R, Li D et al (2014) Human endothelial colony-forming cells serve as trophic mediators for mesenchymal stem cell engraftment via paracrine signaling. Proc Natl Acad Sci USA 111(28):10137–10142. doi:10.1073/pnas.1405388111
9. Falanga V (2005) Wound healing and its impairment in the diabetic foot. Lancet 366(9498):1736–1743. doi:10.1016/S0140-6736(05)67700-8
10. Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341(10):738–746. doi:10.1056/NEJM199909023411006
11. Cha J, Falanga V (2007) Stem cells in cutaneous wound healing. Clin Dermatol 25(1):73–78. doi:10.1016/j.clindermatol.2006.10.002
12. Otero-Vinas M, Falanga V (2016) Mesenchymal stem cells in chronic wounds: the spectrum from basic to advanced therapy. Adv Wound Care 5(4):149–163. doi:10.1089/wound.2015.0627
13. DiPietro LA (2016) Angiogenesis and wound repair: when enough is enough. J Leukoc Biol 100(5):979–984. doi:10.1189/jlb.4MR0316-102R
14. Wu Y, Chen L, Scott PG et al (2007) Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25(10):2648–2659. doi:10.1634/stemcells.2007-0226
15. Wu Y, Zhao RC, Tredget EE (2010) Concise review: bone marrow-derived stem/progenitor cells in cutaneous repair and regeneration. Stem Cells 28(5):905–915. doi:10.1002/stem.420
16. Li M, Zhao Y, Hao H et al (2015) Mesenchymal stem cell-based therapy for nonhealing wounds: today and tomorrow. Wound Repair Regeneration 23(4):465–482. doi:10.1111/wrr.12304
17. Chen L, Tredget EE, Wu PY et al (2008) Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3(4):e1886. doi:10.1371/journal.pone.0001886
18. Li Z, Liu C, Xie Z et al (2011) Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS One 6(6):e20526. doi:10.1371/journal.pone.0020526
19. Wang S, Guo L, Ge J et al (2015) Excess integrins cause lung entrapment of mesenchymal stem cells. Stem Cells 33(11):3315–3326. doi:10.1002/stem.2087
20. Guo L, Zhou Y, Wang S et al (2014) Epigenetic changes of mesenchymal stem cells in three-dimensional (3D) spheroids. J Cell Mol Med 18(10):2009–2019. doi:10.1111/jcmm.12336
21. Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143–147
22. Wang X, Ge J, Tredget EE et al (2013) The mouse excisional wound splinting model, including applications for stem cell transplantation. Nat Protoc 8(2):302–309. doi:10.1038/nprot.2013.002
23. Honczarenko M, Le Y, Swierkowski M et al (2006) Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24(4):1030–1041. doi:10.1634/stemcells.2005-0319
24. Lv FJ, Tuan RS, Cheung KM et al (2014) Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells 32(6):1408–1419. doi:10.1002/stem.1681
25. Chandrakanthan V, Yeola A, Kwan JC et al (2016) PDGF-AB and 5-Azacytidine induce conversion of somatic cells into tissue-regenerative multipotent stem cells. Proc Natl Acad Sci USA 113(16):E2306–E2315. doi:10.1073/pnas.1518244113
26. Zhang Y, Cao N, Huang Y et al (2016) Expandable cardiovascular progenitor cells reprogrammed from fibroblasts. Cell Stem Cell 18(3):368–381. doi:10.1016/j.stem.2016.02.001
27. Ball SG, Shuttleworth A, Kielty CM (2012) Inhibition of platelet-derived growth factor receptor signaling regulates Oct4 and Nanog expression, cell shape, and mesenchymal stem cell potency. Stem Cells 30(3):548–560. doi:10.1002/stem.1015
28. Hung SC, Pochampally RR, Chen SC et al (2007) Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 25(9):2363–2370. doi:10.1634/stemcells.2006-0686
29. Tao H, Han Z, Han ZC et al (2016) Proangiogenic features of mesenchymal stem cells and their therapeutic applications. Stem Cells Int 2016:1314709. doi:10.1155/2016/1314709
30. Laschober GT, Brunauer R, Jamnig A et al (2011) Age-specific changes of mesenchymal stem cells are paralleled by upregulation of CD106 expression as a response to an inflammatory environment. Rejuvenation Res 14(2):119–131. doi:10.1089/rej.2010.1077
31. Winkler EA, Bell RD, Zlokovic BV (2010) Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling. Mol Neurodegeneration 5:32. doi:10.1186/1750-1326-5-32
32. Wu Y, Zhao RC (2012) The role of chemokines in mesenchymal stem cell homing to myocardium. Stem Cell Rev 8(1):243–250. doi:10.1007/s12015-011-9293-z
33. Guo L, Ge J, Zhou Y et al (2014) Three-dimensional spheroid-cultured mesenchymal stem cells devoid of embolism attenuate brain stroke injury after intra-arterial injection. Stem Cells Dev 23(9):978–989. doi:10.1089/scd.2013.0338
34. Baxter MA, Wynn RF, Jowitt SN et al (2004) Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22(5):675–682. doi:10.1634/stemcells.22-5-675
35. Krampera M, Pasini A, Rigo A et al (2005) HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood 106(1):59–66. doi:10.1182/blood-2004-09-3645
36. Fiedler J, Etzel N, Brenner RE (2004) To go or not to go: migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem 93(5):990–998. doi:10.1002/jcb.20219
37. Ball SG, Shuttleworth CA, Kielty CM (2007) Vascular endothelial growth factor can signal through platelet-derived growth factor receptors. J Cell Biol 177(3):489–500. doi:10.1083/jcb.200608093
38. Boomsma RA, Geenen DL (2012) Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis. PLoS One 7(4):e35685. doi:10.1371/journal.pone.0035685
39. Nuschke A (2014) Activity of mesenchymal stem cells in therapies for chronic skin wound healing. Organogenesis 10(1):29–37. doi:10.4161/org.27405
40. Gong Z, Calkins G, Cheng EC et al (2009) Influence of culture medium on smooth muscle cell differentiation from human bone marrow-derived mesenchymal stem cells. Tissue Eng Part A 15(2):319–330. doi:10.1089/ten.tea.2008.0161
41. Tamama K, Sen CK, Wells A (2008) Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway. Stem Cells Dev 17(5):897–908. doi:10.1089/scd.2007.0155